Get a better understanding of the applications and technology of Evosep One, a separation tool designed for clinical omics.
Fast confirmatory analysis of rHuEPOs in plasma for horseracing doping control by coupling Evosep One & Q-Exactive HF
Evosep One has been designed specifically to address and eliminate the prevalent challenges associated with throughput and robustness of nano-flow LC-MS workflows while maintaining sufficient sensitivity and resolving power for clinical omics applications.
CASE STUDY with the max-planck institute
Implementing the Evosep One– a ‘gradient off-set focusing HPLC instrument’– into the workflow at the Max-Planck Institute removed a major hurdle to establishing proteomics as a standard diagnostic method.
Until now, available separation technology has severely limited throughput and robustness but the Evosep One dramatically increases robustness and sample throughput while maintaining the sensitivity of current nanoflow LC instruments.
Evosep One is designed for sensitivity, throughput, and robustness – tailored for large clinical studies. Learn more about our instrument Evosep One, a separation tool designed for clinical omics.
Introducing Evosep One
The Evosep One is an optimized front-end to a mass spectrometer for large-cohort experiments. Watch the video to get a quick overview of the instrument.
A NOVEL LC SYSTEM EMBEDS ANALYTES IN PRE-FORMED GRADIENTS FOR RAPID, ULTRA-ROBUST PROTEOMICS
This paper presents a novel concept that opens entirely new possibilities in proteomics in general and in clinical proteomics. With a simplified design it enables a robust operation over thousands of sample injections and analyzes samples in an extremely robust and high throughput manner, without sacrificing in depth proteomics coverage.
Plasma proteomics goes high throughput – timsTOF Pro with PASEF and 4D feature alignment to quantify 500 plasma proteins in 11.5 min
The timsTOF Pro with PASEF and the Evosep One for biomarker discovery in large sample cohorts of human blood plasma
Evosep One Enables Robust Quantitative Deep Proteome Coverage using Tandem Mass Tags while Significantly Reducing Instrument Time
This paper by Jonathan Krieger, PhD and collagues shows how Evosep One Enables Robust Quantitative Deep Proteome Coverage using Tandem Mass Tags while Significantly Reducing Instrument Time
Online parallel accumulation − serial fragmentation (PASEF) with a novel trapped ion mobility mass spectrometer
In bottom−up proteomics, peptides are separated by liquid chromatography with elution peak widths in the range of seconds, while mass spectra are acquired in about 100 microseconds with time−of−fight (TOF) instruments.
High-Throughput Proteomics Quantification Enabled by Fast LC Separation and Advanced PRM Acquisition
To support proteomics studies the Evosep One combined with Thermo Scientific™ Q Exactive™ are used to develop High-throughput LC-PRM set-ups based on fast LC separations and advanced PRM acquisition schemes. A novel IS-PRM method variant was also developed to further increase the analytical throughput and open the way to fast broad-coverage/multi-pathway monitoring studies.
MAXIMIZED THROUGHPUT AND ANALYTICAL DEPTH FOR SHOTGUN PROTEOMICS USING PASEF ON A TIMS EQUIPPED QTOF
While good analytical depth is currently achievable in (MS)-based proteomics, the throughput required in screening or clinical applications is not achievable with traditional nanoESI LC-MS/MS systems. Combining the Evosep One with low overhead times and the timsTOF Pro with the fast PASEF acquisition method (Meier et al., JPR 2015). We show highly reproducible identification and quantification with low sample amounts over ~100 runs, demonstrating the potential for high throughput applications.
HIGH THROUGHPUT HCP SCREENING IS HERE: > 50 HCPS IDENTIFIED IN 21 MINUTES
Here, the high speed of PASEF, (parallel accumulation and serial fragmentation) as implemented on the timsTOF Pro, coupled with the Evosep One LC system were used to detect HCPs using a 21 minute gradient.
As the protein concentration in plasma is so high (50 μg/μl), a simple fingerprick delivering just 1μl of plasma is enough to analyze the human plasma proteome.
DEVELOPMENT OF A ROBUST AND REPRODUCIBLE METHOD FOR DETECTION OF CITRULLINATION IN COMPLEX SAMPLES
An initial separation by traditional LC using HFBA as ion-pairing reagent followed by short LC-MSMS separation on an EVOSEP system is compared to a traditional LC-MS/MS setup, with the aim of developing a system, where specific ion pairing reagents are used to separate arginine, containing peptides from equivalent citrullinated ones.
DEVELOPMENT OF A NOVEL LC CONCEPT FOR CLINICAL PROTEOMICS
Mass spectrometry based proteomics and metabolomics are fast growing and powerful technologies, with the potential to revolutionize health care and precision medicine. Here we describe a conceptually novel low-flow chromatography system, that delivers the robustness and throughput required for clinical applications while maintaining the sensitivity of current nano-flow LC instrumentation.
HIGH-THROUGHPUT PROTEOMICS QUANTIFICATION ENABLED BY FAST LC SEPARATION AND ADVANCED PRM ACQUISITION
Depth of coverage in shotgun proteomics workflows is usually achieved by high resolution nano-LC peptide separation, coupled to ESI-MS/MS. While good analytical depth is currently achievable, reaching the throughput required to analyze hundreds or even thousands of samples needed to obtain sufficient statistical power for biomarker validation studies, is unachievable with traditional nano-ESI LC-MS/MS systems.
OPTIMIZING DATA PROCESSING PARAMETERS FOR SAMPLES ACQUIRED ON INSTRUMENTS USING ADVANCED PEAK DETERMINATION
Thermo and Evosep’s data from the joint use of the Evosep One system and Thermo’s QExactive mass spectrometers. The samples were measured using an Evosep One coupled to an Q Exactive HF-X Hybrid Quadrupole-Orbitrap mass spectrometer, and the Evotip technology improves overall system throughput and robustness by reducing column clogging and carryover.
TIMSTOF PRO WITH PASEF AND EVOSEP ONE: MAXIMIZING THROUGHPUT, ROBUSTNESS AND ANALYTICAL DEPTH FOR SHOTGUN PROTEOMICS
The recent release of Evosep one, has changed the game, ceasing the need for concatenation and cutting MS analysis time in half. The results presented here demonstrate combining the timsTOF Pro and the Evosep One, for the first time enables high-throughput measurements while maintaining analytical depth.
Thermo Fisher Scientific Announces Collaboration to Revolutionize Profiling of Large Plasma Sample Cohorts in Protein-based Clinical Research Studies
ASMS 2019 – Thermo Fisher Scientific and Evosep have entered into a collaboration to develop high-throughput clinical research proteomics workflows for profiling large plasma sample cohorts for proteomics, translational research and pharmaceutical applications.
Bruker Announces Progress in Advanced Methods and Software Tools for 4D High-Throughput and Ultra-High Sensitivity Proteomics
At the 15th Annual Conference of the US Human Proteome Organization, Bruker announces further progress in high-sensitivity, high-throughput plasma-proteomics using the timsTOF Pro mass spectrometer connected to an Evosep One low-flow chromatography system.
HUPO Moving in Translational, Clinical Direction as HPP Project Approaches Goal
Biognosys and Evosep jointly announced a high-throughput workflow for clinical plasma proteomics that combines Biognosys’ PQ500 plasma protein panel, which quantifies 500 proteins using DIA mass spec, with the Evosep One liquid chromatography system.
BRUKER ANNOUNCES BREAKTHROUGH PROTEOMICS AND LIPIDOMICS WORKFLOW FOR ADVANCES FOR THE TIMSTOF PRO AT HUPO 2018
With the release of a Bruker plug-in to control the Evosep One LC system, Bruker and Evosep now announce a co-selling agreement, which enables Bruker to sell, support and service a complete solution for proteomics labs requiring extreme throughput, sensitivity and robustness.
BIOGNOSYS AND EVOSEP PROMOTE JOINED ROBUST, HIGH-THROUGHPUT WORKFLOWS FOR CLINICAL PLASMA PROTEOMICS
At the 17th Human Proteome Organization World Congress, Biognosys and Evosep jointly promote a robust, high-throughput workflow for clinical research proteomics.
Evosep LC System Enables Mass Spec Throughput of 200 Samples per Day
Researchers from the Max Planck Institute of Biochemistry, University of Copenhagen, and liquid chromatography firm Evosep Biosystems have developed a mass spec-based proteomics workflow capable of running more than 200 samples per day.
Thermo Scientific and Evosep join hands to develop robust, high-throughput workflows for clinical proteomics
At the 66th Conference on Mass Spectrometry and Allied Topics, Thermo Scientific and Evosep announced a joint effort to develop and promote robust, high-throughput workflows for clinical proteomics
Bruker Introduces scimaX™ MRMS for Novel Phenomics Workflows, and Further Enhances the timsTOF™ Pro for PASEF Proteomics at ASMS
In their press release at the 66th ASMS Conference, Bruker announces full integration with the Evosep One separation device with Bruker’s Hystar LC/MS control for high-throughput clinical proteomics of up to 200 samples per day. This novel combination delivers superb sensitivity (50 ng HeLa) and high throughput for LFQ of ~1,200 proteins in only ~5 minutes.
ASMS recap by genome web
To further increase throughput, Mann and his colleagues combined the timsTOF Pro with the Evosep One LC system, which uses a preformed gradient to improve assay robustness and cut downtime between injections.
journal of integrated omics: shotgun proteomics: where do we stand now?
Making a sample ready for shoutgun proteomics analysis has always been a timeconsuming operation. However, new techniological advances in chromatpgraphy are called to change the panorama dramatically.
Bruker and Evosep Announce New Integrated Clinical Research Proteomics Solution to Quantify Over a Thousand Proteins in Five Minutes
At the 2018 US HUPO Conference, Bruker and Evosep announce that they have executed a co-development and co-marketing agreement for the Evosep One chromatography system to work seamlessly with Bruker’s timsTOF Pro ultra-high resolution quadrupole time of flight mass spectrometer.
Bruker Highlights Innovative Analytical Solutions and Systems at Pittcon 2018
At Pittcon 2018, Bruker this week will highlight various innovative analytical systems and new high-value solutions – Bruker’s revolutionary timsTOF Pro mass spectrometer for high sensitivity proteomics can now be integrated with the Evosep One separation device for high-throughput clinical proteomics.
Evosep Introduces A Novel Separation Solution Designed for Clinical Omics at HUPO 2017
Today, the Evosep One is introduced, a novel separation solution designed for fast and robust separation of omics samples in large clinical cohort studies (primarily proteomics and metabolomics).
SEMINARS and webinars
High-throughput proteomics with evosep one
Webinar: Targeted assay development for quantifying protein half-life over a range of mouse tissues
A Standardized Plasma Proteome Profiling Workflow for Large Sample Cohorts
Increasing throughput: from pre-clinical models to protein complexes
How to get speed and depth in your host cell protein
Webinar on Fast HCP Screening with Evosep One and timsTOF Pro.
RAPID PROTEOME ANALYSES USING THE EVOSEP ONE BY PROF. OLSEN
Breakfast seminar at ASMS 2018 by Prof. Jesper Olsen from Novo Nordisk Foundation Center for Protein Research in Copenhagen.
HUPO 2017 LUNCH SEMINAR ON CLINICAL PROTEOMICS, Part 1.
“Robust Front-End Solutions for Clinical Proteomics”,
By Dr. Ole Vorm, Founder and Director, Evosep
HUPO 2017 LUNCH SEMINAR ON CLINICAL PROTEOMICS, part 2.
“Perspectives of clinical proteomics for precision medicine and the resulting demands on front-end separation for mass spectrometric analysis.”,
By Professor Matthias Mann, MPI, Martinsried
Experts on clinical proteomics
HCP ANALYSIS AT ALPHALYSE REQUIRES ROBUST HIGH THROUGHPUT LCMS
The Evosep One is an optimized front-end to a mass spectrometer for large-cohort experiments.
MEDICAL DOCTOR DAN HOLMES TALKS ABOUT THE CURRENT STATE OF CLINICAL PROTEOMICS
Associate professor Dan Holmes is a medical doctor and Division Head, Clinical Chemistry, St. Paul’s Hospital in Vancouver.
AKHILESH PANDEY FROM JOHNS HOPKINS ABOUT CLINICAL PROTEOMICS
“Robust Front-End Solutions for Clinical Proteomics”, talk by Dr. Ole Vorm, Founder and Director, Evosep.
DR. THOMAS CONRADS ABOUT CLINICAL PROTEOMICS AND APOLLO
Dr. Conrads explains how clinical proteomics can improve cancer treatment with early detection, molecular diagnosis and increased precision.
Prof. Phil Robinson ABOUT CLINICAL PROTEOMICS
Professor Phil Robinson from ProCan in Sydney.